Hunter, III; Robert Neil

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hunter, III; Robert Neil.The latest application filed is for "glucagon-receptor selective polypeptides and methods of use thereof".

Company Profile

2.9.4

Hunter, III; Robert Neil - Boston MA
Hunter, III; Robert Neil - Research Triangle Park NC
Hunter, III; Robert Neil - Durham NC
Hunter, III; Robert Neil - Raleigh NC

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glucagon-receptor selective polypeptides and methods of use thereof Grant 11,214,607 - Blackwell , et al. January 4, 2	2022-01-04
Glucagon-receptor Selective Polypeptides And Methods Of Use Thereof App 20200299350 - Blackwell; William ; et al.	2020-09-24
Glucagon-receptor selective polypeptides and methods of use thereof Grant 10,501,517 - Blackwell , et al. Dec	2019-12-10
Peptide YY analogs Grant 9,441,023 - Dock , et al. September 13, 2	2016-09-13
Therapeutic Peptides App 20160108098 - DOCK; Steven Thomas ; et al.	2016-04-21
Therapeutic Peptides App 20140329742 - Dock; Steven Thomas ; et al.	2014-11-06
Chemical Compounds App 20080293716 - Drewry; David Harold ; et al.	2008-11-27
Chemical compounds Grant 7,329,678 - Drewry , et al. February 12, 2	2008-02-12
Substituted oxindole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors and compositions and methods of treating chemotherapy and radiation therapy side effects Grant 7,105,529 - Davis , et al. September 12, 2	2006-09-12
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors Grant 6,541,503 - Davis , et al. April 1, 2	2003-04-01
Substituted oxindole derivatives as protein tyrosine kinase and as protein serine/threonine kinase inhibitors Grant 6,387,919 - Davis , et al. May 14, 2	2002-05-14
Substituted oxidole derivatives as protein tyrosine and as protein serine/threonine kinase inhibitors Grant 6,369,086 - Davis , et al. April 9, 2	2002-04-09
Benzylidene-1,3-dihydro-indol-2-one derivatives a receptor tyrosine kinase inhibitors, particularly of Raf kinases Grant 6,268,391 - Dickerson , et al. July 31, 2	2001-07-31

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.